Glucocorticosteroid: A Review by Rahel Woldo PharmD

GLUCOCORTICOSTEROID (GC) – Review
Rahel Woldu, PharmD
University of Colorado Health Sciences Center
September 9, 2003

Introduction (1,2)
• It is estimated that more than 5 million patients are treated with GCs annually.
• The anti-inflammatory and immunosuppressive effects of steroids have been exploited in the treatment of diseases such as; bronchial asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, collagen vascular diseases, chronic active hepatitis and certain forms of nephritides.

Muromonab-CD3 (OKT-3) by Kimberly Fischer, RN BSN

Muromonab-CD3 is a mouse antibody produced from fusion of mouse plasma cells with human B-cell myeloma cells, targeting human T-cell CD-3. This mouse IgG2a was first approved in 1986 by FDA to be used in organ transplant rejection. It coats or binds to CD-3, T-cell surface proteins, subjecting OKT-3/CD-3 complex to opsonization by the reticuloendothelial system in the liver with the first dose. The first dose of OKT-3 cause massive activation and subsequent depletion of oT-helper cells within the first day.

Hiring Transplant Pharmacist in Colorado

University of Colorado Hospital (UCH) is seeking a Clinical Pharmacist for our Transplant Unit who will be an active member of our interdisciplinary team. As a pioneer in the field of transplant services, UCH understands the importance of a collaborative approach to the successful recovery of a transplant patient. As the only academic hospital in the state of Colorado, UCH leads the way in the most advanced care.

Changes in Heparin Potency

By Lance S. Lindberg, Pharm.D.

Syndicate content